Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gen Physiol Biophys ; 36(5): 521-529, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29372685

RESUMO

DNA methylation is a significant epigenetic modification which plays a key role in regulation of gene expression and influences functional changes in endometrial tissue. Aberrant DNA methylation changes result in deregulation of important apoptotic proteins during endometrial carcinogenesis and apoptosis resistance development. Evading apoptosis is still a major problem in the successful treatment of endometrial cancer patients. The aim of our study was to examine the promoter DNA methylation changes in 22 apoptosis-associated genes in endometrioid endometrial cancer patients, precancerous lesions and healthy tissue from various normal menstrual cycle phases using a unique pre-designed methylation platform. We observed as the first a significant difference in promoter DNA methylation status in genes: BCL2L11 (p < 0.001), CIDEB (p < 0.03) and GADD45A (p < 0.05) during endometrial carcinogenesis and BIK gene (p < 0.03) in different phases of normal menstrual cycle. The results of our study indicate that deregulation of mitochondrial apoptotic pathway can considerably contributes to the apoptosis resistance development and may be helpful in identifying of new potent biomarkers in endometrial cancer.


Assuntos
Proteínas Reguladoras de Apoptose/genética , Apoptose/genética , Metilação de DNA/genética , DNA de Neoplasias/genética , Neoplasias do Endométrio/genética , Epigênese Genética/genética , Lesões Pré-Cancerosas/genética , Adulto , Idoso , Carcinogênese/genética , Feminino , Predisposição Genética para Doença/genética , Humanos , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único/genética , Eslováquia
2.
J Neuroimmunol ; 282: 80-4, 2015 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-25903732

RESUMO

In this study, we determined the association between rs6897932 in interleukin 7 receptor α (IL7Ra) gene and the risk and disability progression of multiple sclerosis (MS) in 270 MS patients and 303 controls. We found allele C to be associated with the risk of MS and minor allele T to be protective against MS development. Moreover, we revealed for the first time that rs6897932 in IL7Ra gene is associated with the progression of MS, evaluated by MSSS scores. The minor allele T and genotype TT are protective against a rapid disability progression in MS in the Central European Slovak population.


Assuntos
Pessoas com Deficiência , Predisposição Genética para Doença/genética , Subunidade alfa de Receptor de Interleucina-7/genética , Esclerose Múltipla/genética , Esclerose Múltipla/fisiopatologia , Polimorfismo de Nucleotídeo Único/genética , Adulto , Progressão da Doença , Feminino , Frequência do Gene , Estudos de Associação Genética , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Eslováquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...